Home » GlaxoSmithKline’s Arixtra Gets European Nod for Acute Coronary Syndromes
GlaxoSmithKline’s Arixtra Gets European Nod for Acute Coronary Syndromes
The European Medicines Agency approved GlaxoSmithKline PLC’s Arixtra anticoagulant drug for use as a treatment for acute coronary syndromes, the company said Monday.
MarketWatch
Upcoming Events
-
23Apr
-
25Apr
-
07May
-
14May
-
30May